Find a Commonwealth Resource
Rivaroxaban
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Rivaroxaban is a prescription oral tablet medication that acts as a Factor Xa inhibitor to help prevent blood clots. It is available in strengths of 2.5 mg, 10 mg, 15 mg, and 20 mg, manufactured by Florida Pharmaceutical Products, LLC under application ANDA218445. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Rivaroxaban
Access the FDA dataset for Rivaroxaban — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026